
Sergio Coffa
Examiner (ID: 9524, Phone: (571)270-3022 , Office: P/1675 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1676, 1658, 1654, 1675 |
| Total Applications | 897 |
| Issued Applications | 440 |
| Pending Applications | 134 |
| Abandoned Applications | 351 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16892080
[patent_doc_number] => 11033607
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Peptides and methods for preventing ischemic tissue injury
[patent_app_type] => utility
[patent_app_number] => 14/438375
[patent_app_country] => US
[patent_app_date] => 2013-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 8093
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14438375
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/438375 | Peptides and methods for preventing ischemic tissue injury | Oct 27, 2013 | Issued |
Array
(
[id] => 9757311
[patent_doc_number] => 20140288012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'METHODS FOR THE PREVENTION AND TREATMENT OF BURN INJURIES AND SECONDARY COMPLICATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/061370
[patent_app_country] => US
[patent_app_date] => 2013-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 18293
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14061370
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/061370 | Methods for the prevention and treatment of burn injuries and secondary complications | Oct 22, 2013 | Issued |
Array
(
[id] => 10361087
[patent_doc_number] => 20150246092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-03
[patent_title] => 'METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH'
[patent_app_type] => utility
[patent_app_number] => 14/437325
[patent_app_country] => US
[patent_app_date] => 2013-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 34233
[patent_no_of_claims] => 117
[patent_no_of_ind_claims] => 69
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14437325
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/437325 | METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH | Oct 21, 2013 | Abandoned |
Array
(
[id] => 9307067
[patent_doc_number] => 20140045741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'Method Of Treating An Ocular Disease And Compositions Effective For Treating An Ocular Disease'
[patent_app_type] => utility
[patent_app_number] => 14/059035
[patent_app_country] => US
[patent_app_date] => 2013-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4978
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14059035
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/059035 | Method Of Treating An Ocular Disease And Compositions Effective For Treating An Ocular Disease | Oct 20, 2013 | Abandoned |
Array
(
[id] => 9560588
[patent_doc_number] => 20140178301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'POLYPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 14/055443
[patent_app_country] => US
[patent_app_date] => 2013-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 21845
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14055443
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/055443 | Polypeptides | Oct 15, 2013 | Issued |
Array
(
[id] => 10388014
[patent_doc_number] => 20150273021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'COMPOSITIONS AND METHODS FOR SUSTAINED DELIVERY OF GLUCAGON-LIKE PEPTIDE (GLP-1) RECEPTOR AGONIST THERAPEUTICS'
[patent_app_type] => utility
[patent_app_number] => 14/434022
[patent_app_country] => US
[patent_app_date] => 2013-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 31031
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14434022
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/434022 | COMPOSITIONS AND METHODS FOR SUSTAINED DELIVERY OF GLUCAGON-LIKE PEPTIDE (GLP-1) RECEPTOR AGONIST THERAPEUTICS | Oct 10, 2013 | Abandoned |
Array
(
[id] => 10388003
[patent_doc_number] => 20150273010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'HIGH-THROUGHPUT ASSAYS FOR HIV-1 ENVELOPE MATURATION AND NOVEL PEPTIDE INHIBITORS AGAINST HIV-1'
[patent_app_type] => utility
[patent_app_number] => 14/434622
[patent_app_country] => US
[patent_app_date] => 2013-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 19853
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14434622
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/434622 | HIGH-THROUGHPUT ASSAYS FOR HIV-1 ENVELOPE MATURATION AND NOVEL PEPTIDE INHIBITORS AGAINST HIV-1 | Oct 8, 2013 | Abandoned |
Array
(
[id] => 11479307
[patent_doc_number] => 09585828
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-07
[patent_title] => 'Proteoglycan-containing material'
[patent_app_type] => utility
[patent_app_number] => 14/046160
[patent_app_country] => US
[patent_app_date] => 2013-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 16
[patent_no_of_words] => 15068
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14046160
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/046160 | Proteoglycan-containing material | Oct 3, 2013 | Issued |
Array
(
[id] => 9205936
[patent_doc_number] => 20140005113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'TREATMENT OF DISORDERS WITH ALTERED VASCULAR BARRIER FUNCTION'
[patent_app_type] => utility
[patent_app_number] => 14/022475
[patent_app_country] => US
[patent_app_date] => 2013-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8614
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14022475
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/022475 | TREATMENT OF DISORDERS WITH ALTERED VASCULAR BARRIER FUNCTION | Sep 9, 2013 | Abandoned |
Array
(
[id] => 10340449
[patent_doc_number] => 20150225454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-13
[patent_title] => 'TETRABRANCHED PEPTIDES AND ANALOGUES AS A NEW CLASS OF ANTIMICROBIALS AND THEIR PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/426822
[patent_app_country] => US
[patent_app_date] => 2013-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12557
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14426822
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/426822 | TETRABRANCHED PEPTIDES AND ANALOGUES AS A NEW CLASS OF ANTIMICROBIALS AND THEIR PREPARATION THEREOF | Sep 8, 2013 | Abandoned |
Array
(
[id] => 10317326
[patent_doc_number] => 20150202329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-23
[patent_title] => 'Methods and Composition for Detecting Intestinal Cell-Barrier Dysfunction'
[patent_app_type] => utility
[patent_app_number] => 14/424224
[patent_app_country] => US
[patent_app_date] => 2013-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8351
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14424224
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/424224 | Methods and Composition for Detecting Intestinal Cell-Barrier Dysfunction | Sep 4, 2013 | Abandoned |
Array
(
[id] => 9537143
[patent_doc_number] => 20140161786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'Therapeutic compositions and related methods'
[patent_app_type] => utility
[patent_app_number] => 13/987770
[patent_app_country] => US
[patent_app_date] => 2013-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12218
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13987770
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/987770 | Therapeutic compositions and related methods | Aug 28, 2013 | Abandoned |
Array
(
[id] => 9263210
[patent_doc_number] => 20130345139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'COMPOSITION FOR NUTRITION PURPOSES'
[patent_app_type] => utility
[patent_app_number] => 14/011924
[patent_app_country] => US
[patent_app_date] => 2013-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2795
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14011924
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/011924 | COMPOSITION FOR NUTRITION PURPOSES | Aug 27, 2013 | Abandoned |
Array
(
[id] => 10333535
[patent_doc_number] => 20150218539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'METHODS OF USING THE CALCINEURIN A VARIANT CNAB1 FOR THE TREATMENT OF CARDIAC HYPERTROPHY'
[patent_app_type] => utility
[patent_app_number] => 14/422112
[patent_app_country] => US
[patent_app_date] => 2013-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11798
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14422112
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/422112 | METHODS OF USING THE CALCINEURIN A VARIANT CNAB1 FOR THE TREATMENT OF CARDIAC HYPERTROPHY | Aug 15, 2013 | Abandoned |
Array
(
[id] => 9162045
[patent_doc_number] => 20130310322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'ISOLATED EXTRACELLULAR MATRIX MATERIAL INCLUDING SUBSEROUS FASCIA'
[patent_app_type] => utility
[patent_app_number] => 13/951631
[patent_app_country] => US
[patent_app_date] => 2013-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12078
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13951631
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/951631 | Isolated extracellular matrix material including subserous fascia | Jul 25, 2013 | Issued |
Array
(
[id] => 11814923
[patent_doc_number] => 09718865
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-01
[patent_title] => 'Sodium channel blocking peptides and the use thereof'
[patent_app_type] => utility
[patent_app_number] => 14/417394
[patent_app_country] => US
[patent_app_date] => 2013-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15824
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14417394
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/417394 | Sodium channel blocking peptides and the use thereof | Jul 25, 2013 | Issued |
Array
(
[id] => 10452013
[patent_doc_number] => 20150337026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'PEPTIDE-BASED COMPOUNDS AND USES THEREOF TO TREAT BETA-AMYLOID ACCUMULATION'
[patent_app_type] => utility
[patent_app_number] => 14/416956
[patent_app_country] => US
[patent_app_date] => 2013-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16482
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14416956
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/416956 | Peptide-based compounds and uses thereof to treat beta-amyloid accumulation | Jul 23, 2013 | Issued |
Array
(
[id] => 9160915
[patent_doc_number] => 20130309192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'Auristatin Compounds and Conjugates Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/944561
[patent_app_country] => US
[patent_app_date] => 2013-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 54290
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13944561
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/944561 | Auristatin compounds and conjugates thereof | Jul 16, 2013 | Issued |
Array
(
[id] => 12302640
[patent_doc_number] => 09937235
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-10
[patent_title] => Lipidated peptides as anti-obesity agents
[patent_app_type] => utility
[patent_app_number] => 14/414034
[patent_app_country] => US
[patent_app_date] => 2013-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 11990
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14414034
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/414034 | Lipidated peptides as anti-obesity agents | Jul 10, 2013 | Issued |
Array
(
[id] => 9205937
[patent_doc_number] => 20140005114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/926766
[patent_app_country] => US
[patent_app_date] => 2013-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19510
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13926766
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/926766 | β-arrestin effectors and compositions and methods of use thereof | Jun 24, 2013 | Issued |